Next Article in Journal
Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors
Previous Article in Journal
The Expression of Embryonic Liver Development Genes in Hepatitis C Induced Cirrhosis and Hepatocellular Carcinoma
Previous Article in Special Issue
Endometrial Serous Carcinoma: Its Molecular Characteristics and Histology-Specific Treatment Strategies
Cancers 2012, 4(4), 969-988; doi:10.3390/cancers4040969
Review

Estrogen Signaling in Lung Cancer: An Opportunity for Novel Therapy

1,2,*  and 1,2
1 Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA 98109, USA 2 Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
* Author to whom correspondence should be addressed.
Received: 4 July 2012 / Revised: 9 August 2012 / Accepted: 10 September 2012 / Published: 25 September 2012
(This article belongs to the Special Issue Hormones and Carcinogenesis)
View Full-Text   |   Download PDF [190 KB, uploaded 25 September 2012]
SciFeed

Abstract

Lung cancer is the leading cause of cancer death in U.S. and represents a major public health burden. Epidemiologic data have suggested that lung cancer in women may possess different biological characteristics compared to men, as evidenced by a higher proportion of never-smokers among women with lung cancer. Emerging data indicate that female hormones such as estrogen and progesterone play a significant role in lung carcinogenesis. It has been reported that estrogen and progesterone receptors are expressed in lung cancer cell lines as well as in patient-derived tumors. Hormone related risk factors such as hormone replacement therapy have been implicated in lung carcinogenesis and several preclinical studies show activity of anti-estrogen therapy in lung cancer. In this review, we summarize the emerging evidence for the role of reproductive hormones in lung cancer and implications for lung cancer therapy.
Keywords: lung cancer; estrogen; progesterone; aromatase; hormone receptors lung cancer; estrogen; progesterone; aromatase; hormone receptors
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
RIS
MDPI and ACS Style

Baik, C.S.; Eaton, K.D. Estrogen Signaling in Lung Cancer: An Opportunity for Novel Therapy. Cancers 2012, 4, 969-988.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert